InvestorsHub Logo
Followers 85
Posts 314
Boards Moderated 0
Alias Born 06/20/2020

Re: None

Friday, 10/02/2020 2:43:46 PM

Friday, October 02, 2020 2:43:46 PM

Post# of 198661
"The Gates-funded Coronavirus Immunotherapy Consortium is building a library of COVID-19 monoclonals and comparing them side by side on a wide range of metrics. Companies and research labs have offered up 100 antibodies so far, and another 100 are expected, said director Erica Saphire, of the La Jolla Institute for Immunology.

“It’s going to be the largest, deepest, broadest database of how antibodies perform against the [novel] coronavirus,” Saphire said. The Gates Foundation is looking for the most potent candidates and combinations, along with those that can be easily and more cheaply produced. They’re also interested in drugs that can be formulated for delivery via injection or pill, rather than infusion.

“Their mandate to me was to look among all the different antibodies going forward and figure out which … can be used to save lives in low-income countries,” Saphire said.

Think BioClonetics, Monoclonal Antibodies innovators w/ Duke PHD who previously rec'd $32M from Gates Foundation for HIV research in 2017 will get a look? I think they will be involved in this effort without a doubt and will get major funding from private and governmental resources. Dr. Cotropia is a world recognized leader in monoclonal antibodies and discovered "CLONE 3"

DOLLAR$

SOURCE:

https://www.seattletimes.com/seattle-news/health/monoclonal-antibodies-could-fill-the-covid-19-treatment-gap-until-vaccines-arrive-but-at-a-cost/

https://twitter.com/UncleBillyMoney/status/1312099902906724352?s=20
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENZC News